Bruce Booth (Other) sold 231,007 shares of Kymera Therapeutics, Inc. (KYMR) at $108.14 per share, totaling approximately $24.98M.
Insider sales can be driven by various factors including portfolio diversification, tax obligations, or pre-arranged trading plans and do not necessarily reflect a negative outlook.